Display options
Share it on

Biol Open. 2017 Apr 15;6(4):489-495. doi: 10.1242/bio.024133.

Tanshinone IIA suppresses the progression of atherosclerosis by inhibiting the apoptosis of vascular smooth muscle cells and the proliferation and migration of macrophages induced by ox-LDL.

Biology open

Baocai Wang, Zhenwei Ge, Zhaoyun Cheng, Ziniu Zhao

Affiliations

  1. Department of Cardiovascular Surgery, Henan Provincial People's Hospital, Zhengzhou 450003, People's Republic of China.
  2. Department of Cardiovascular Surgery, Henan Provincial People's Hospital, Zhengzhou 450003, People's Republic of China [email protected].

PMID: 28412716 PMCID: PMC5399561 DOI: 10.1242/bio.024133

Abstract

The profound inhibitory effect of Tanshinone IIA (Tan IIA) on atherosclerosis has been demonstrated, whereas the latent mechanism is not completely cleared. This study aimed to investigate the cellular and molecular mechanisms underlying Tan IIA protecting against atherosclerosis. Oil Red O staining and ELISA assay showed that Tan IIA suppressed the progress of atherosclerosis and reduced the levels of inflammatory cytokines in serum of apolipoprotein E deficient (ApoE

© 2017. Published by The Company of Biologists Ltd.

Keywords: Atherosclerosis; Macrophages; Tanshinone IIA; Vascular smooth muscle cells; ox-LDL

References

  1. N Engl J Med. 1989 Apr 6;320(14):915-24 - PubMed
  2. Steroids. 2010 Apr;75(4-5):355-61 - PubMed
  3. Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):e35-44 - PubMed
  4. Circ Res. 2005 Apr 1;96(6):635-42 - PubMed
  5. Arch Biochem Biophys. 2011 Nov;515(1-2):72-9 - PubMed
  6. Immunobiology. 2013 Nov;218(11):1376-84 - PubMed
  7. Diabetes. 2004 Apr;53(4):1068-73 - PubMed
  8. Br J Pharmacol. 2001 Apr;132(7):1531-41 - PubMed
  9. Vascul Pharmacol. 2007 Jun;46(6):427-38 - PubMed
  10. Circ Res. 2007 Mar 16;100(5):607-21 - PubMed
  11. Eur J Pharmacol. 2011 Jan 10;650(1):275-84 - PubMed
  12. Nature. 2000 Sep 14;407(6801):233-41 - PubMed
  13. Cardiovasc Res. 2009 May 1;82(2):371-81 - PubMed
  14. Science. 2015 Jul 17;349(6245):316-20 - PubMed
  15. Nat Rev Immunol. 2013 Oct;13(10):709-21 - PubMed
  16. Nat Med. 2006 Sep;12(9):1075-80 - PubMed
  17. Free Radic Res. 2000 Sep;33(3):305-12 - PubMed
  18. Curr Opin Lipidol. 2012 Oct;23(5):429-38 - PubMed
  19. Biomed Mater Eng. 2014;24(6):3815-24 - PubMed
  20. Arterioscler Thromb Vasc Biol. 2008 May;28(5):812-9 - PubMed
  21. Inflammation. 2016 Feb;39(1):375-84 - PubMed
  22. Arterioscler Thromb Vasc Biol. 2007 May;27(5):996-1003 - PubMed
  23. Mediators Inflamm. 2013;2013:152786 - PubMed
  24. Nat Rev Immunol. 2011 Oct 14;11(11):723-37 - PubMed
  25. J Ethnopharmacol. 2008 Jan 17;115(2):217-22 - PubMed
  26. Acta Physiol (Oxf). 2015 May;214(1):33-50 - PubMed
  27. Exp Toxicol Pathol. 2012 Jul;64(5):453-8 - PubMed
  28. Med Sci Monit. 2015 Dec 29;21:4081-9 - PubMed
  29. Am J Pathol. 1997 Sep;151(3):697-705 - PubMed
  30. FEBS Lett. 2016 Feb;590(4):520-32 - PubMed
  31. Evid Based Complement Alternat Med. 2014;2014:267976 - PubMed
  32. Cell Signal. 2013 Nov;25(11):2255-62 - PubMed

Publication Types